Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that in patients with alopecia areata, trichoscopy was a valuable tool for monitoring disease activity, severity, and therapeutic response, showing changes in trichoscopic markers that preceded improvements observed in the hair pull test.

This study found that trichoscopy is a useful tool in differentiating between alopecia areta and trichotillomania on the eyebrows based on distinct hair and follicle features.

This study found that yellow dots, black dots, exclamation mark hairs, broken hairs, and nail changes observed through dermoscopy are related to the severe form of alopecia areata.

This study found that short vellus hair and yellow dots are common dermoscopic findings in alopecia areata, with variations indicating disease activity or remission.

This study found that yellow dots were the most common trichoscopic finding in adult patients with alopecia areata, observed in 88.5% of cases.

This observational study found that trichoscopy is a reliable tool for diagnosing various hair and scalp disorders, with common findings observed for different types of alopecia.

This report describes five cases of bitemporal alopecia areata with frontal hairline involvement, detailing their management strategies and highlighting potential differential diagnoses, but does not present new clinical results.

This study reported that different types of alopecia have distinctive dermoscopic patterns, which aids in their diagnosis.

This resource outlines the focus areas of the Madridge Journal of Dermatology & Research and reports no new clinical findings.

This article reviews the use of dermoscopy as a noninvasive tool for diagnosing various types of nonscarring alopecia but presents no new clinical findings.

Trichoscopy helps tell different hair loss types apart using specific scalp and hair patterns.

This paper reviews the differential diagnoses and diagnostic tests to distinguish alopecia areata from other types of hair loss, without providing new clinical findings.

The document concludes that skin and nail changes can indicate various underlying health conditions.

This article reviews the history and medical literature on minoxidil, highlighting its approved topical use for hair disorders like androgenic alopecia and potential new applications, such as in yellow nail syndrome and vitiligo treatment alongside phototherapy.

This study analyzed trichoscopic features of discoid lupus erythematosus on the scalp in skin of color and found distinct patterns based on clinical morphology.

This study developed a natural hair dye using Coreopsis tinctoria Nutt. extract, finding that it produced yellow to dark brown colors depending on the treatment, with ferrous lactate enhancing dye performance and color stability after washing.

In this prospective study, 15 patients with patchy alopecia areata treated with intralesional methotrexate every two weeks showed a significant improvement in hair regrowth and reduction in lesion severity, with changes linked to decreased tissue levels of TNF-α.

In this narrative review, researchers found preliminary evidence suggesting that minoxidil, both topical and oral, may enhance nail growth and improve nail strength and appearance, though more extensive studies are needed to confirm its efficacy and safety for this off-label use.

In this study, researchers characterized the clinical features of ophiasis, an uncommon type of alopecia areata, and proposed a new subtype classification that may help predict treatment response and guide management, noting that ophiasis generally has a chronic and refractory nature.

In this case study, trichoscopy was found to be a valuable non-invasive tool for diagnosing dissecting cellulitis of the scalp, enabling early detection and intervention to prevent disease progression and reduce the need for invasive procedures.

Among female patients experiencing hair loss, this study found telogen effluvium to be the most common type, significantly linked to low ferritin levels, while traction alopecia was more prevalent among those wearing headscarves.

In this hospital-based cross-sectional study, researchers found that alopecia is more prevalent in younger patients, with alopecia areata and lichen planopilaris being the most common types among noncicatricial and cicatricial cases, respectively; additionally, thyroid abnormalities were frequently associated with both types of alopecia.

This study found that trichoscopy is highly effective for diagnosing different types of alopecia, showing an average diagnostic accuracy of 90–95%, with specific features aiding in differentiating forms like androgenetic alopecia and alopecia areata. New technologies and AI improve interpretation objectivity, suggesting expanded clinical integration.

This study found that Trichoscope can effectively reveal clinical features of alopecia areata and androgenic alopecia, making it a useful tool for diagnosis and monitoring.

This study observed that in a series of 28 patients with different types of alopecia, specific trichoscopic markers like exclamation-mark hairs and yellow dots helped distinguish alopecia areata from conditions like lichen planopilaris and discoid lupus erythematosus, which showed follicular ostia loss and white scarring.

In this observational study, researchers found that alopecia areata is associated with specific trichoscopic features, such as black dots, yellow dots, and vellus hair, and highlighted trichoptilosis as a potential overlap feature with other hair disorders, suggesting a need for further differentiation between these conditions.

In this institution-based randomized trial, oral betamethasone mini-pulse therapy for alopecia areata showed a faster therapeutic response compared to oral tofacitinib, as measured by trichoscopic changes and achievement of 50% hair regrowth.

This study found that specific dermoscopic markers, including yellow dots and black dots, are associated with poor prognosis in alopecia areata patients, while vellus hair indicates a more favorable outcome.

In this study, researchers characterized alopecia areata incognita in men, finding that all 29 male patients had concurrent androgenetic alopecia, and treatment with ultra-potent topical corticosteroids and minoxidil led to remission in 4-8 months.

This study involved using smartphone applications and low-cost trichoscopy devices to assess various hair and scalp conditions, with diagnoses confirmed through detailed imaging during remote consultations and in-person evaluations.